title: Transmyocardial laser revascularization: from randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions.
abstract: Cardiac surgeons are increasingly faced with a more complex patient who has developed a pattern of diffuse coronary artery disease that cannot be completely revascularized by CAGB alone. Considering the increased operative and long-term cardiac risks predicted by incomplete revascularization, and the documented operative and long-term benefits associated with sole therapy and adjunctive TMR in randomized patients with diffuse coronary artery disease, increased use of sole therapy and adjunctive TMR therapy is warranted.
authors.affiliation: Department of Cardiothoracic Surgery, Mid America Heart Institute, St. Luke's Hospital, 4320 Wornall Road, Suite 50, Kansas City, MO 64111, USA. kallen2340@aol.com
authors.forename: Keith B
authors.initials: KB
authors.lastname: Allen
authors.forename: James
authors.initials: J
authors.lastname: Kelly
authors.forename: A Michael
authors.initials: AM
authors.lastname: Borkon
authors.forename: R Scott
authors.initials: RS
authors.lastname: Stuart
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Daon
authors.forename: Alexander F
authors.initials: AF
authors.lastname: Pak
authors.forename: George L
authors.initials: GL
authors.lastname: Zorn
authors.forename: Michelle
authors.initials: M
authors.lastname: Haines